Interview with the CEO and Director: Antibe Therapeutics Inc. (OTCMKTS:ATBPF)
Daniel Legault, J.D., is Chief Executive Officer and Director of Antibe Therapeutics Inc. Mr. Legault is an entrepreneur and executive with extensive experience in guiding early-stage businesses. He has served as CEO of Antibe Therapeutics Inc. since its formation in May 2009. Mr. Legault is a director and audit committee member of Green Shield Canada, one of the country’s largest health benefits administrators. He is a member of the Law Society of Upper Canada and the New York Bar, and holds a J.D. from Queen’s University. Profile
TWST: Can you describe your company briefly?
Mr. Legault: Antibe Therapeutics is a Canadian pharma company. We are a classic biotech really, and public on the